DOE to fund U.S. Mo-99 production

By staff writers

February 21, 2019 -- The U.S. Department of Energy's (DOE) National Nuclear Security Administration (NNSA) has set the stage to begin negotiations with four companies to produce molybdenum-99 (Mo-99) in the U.S.

The agency has completed its evaluation of applications for funding of Mo-99 production without highly enriched uranium (HEU). It has selected four companies as possible recipients based on the recommendations of an independent technical review panel:

  • NorthStar Medical Radioisotopes of Beloit, WI
  • Shine Medical Technologies of Janesville, WI
  • Northwest Medical Isotopes of Corvallis, OR
  • Niowave of Lansing, MI

With funding support from Congress, the NNSA could allocate as much as $15 million for each company, with a long-range goal of supplying approximately 3,000 six-day Ci of Mo-99 per week in the U.S.

In addition, the NNSA will continue funding the National Laboratories to advance industry efforts to produce Mo-99 without HEU.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking